Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $5.4000 (-6.57%) ($5.2000 - $5.8000) on Wed. Apr. 17, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.06% (three month average) | RSI | 52 | Latest Price | $5.4000(-6.57%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -1.4% a day on average for past five trading days. | Weekly Trend | CAPR declines -0.4% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) VXX(87%) PCY(12%) XBI(12%) LIT(10%) EWY(9%) | Factors Impacting CAPR price | CAPR will decline at least -3.03% in a week (0% probabilities). URA(-23%) XLE(-17%) USO(-16%) BLOK(-16%) XOP(-15%) | | | | | Relative Volatility | | | | Market Trend Strength | -3.03% (StdDev 6.06%) | Hourly BBV | 0 () | Intraday Trend | -6.9% | | | |
|
Resistance Level | $5.73 | 5 Day Moving Average | $5.68(-4.93%) | 10 Day Moving Average | $5.74(-5.92%) | 20 Day Moving Average | $5.73(-5.76%) | To recent high | -18.8% | To recent low | 8% | Market Cap | $106m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |